Intratumoral Heterogeneity for Inactivating Frameshift Mutation of CYB5R2 Gene in Colorectal Cancers

  • Yun Sol Jo
  • Min Sung Kim
  • Nam Jin Yoo
  • Sug Hyung Lee
Letter to the Editor



This work was supported by a grant from National Research Foundation of Korea (2012R1A5A2047939).

Compliance with Ethical Standards

Conflict of Interests

The authors declare no competing interests.


  1. 1.
    Devaney JM, Wang S, Funda S, Long J, Taghipour DJ, Furbert-Harris P, Ittmann M, Kwabi-Addo B (2013) Identification of novel DNA-methylated genes that correlate with human prostate cancer and high-grade prostatic intraepithelial neoplasia. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. Prostate Cancer Prostatic Dis 16:292–300CrossRefPubMedGoogle Scholar
  2. 2.
    X X, Zhao W, Tian F, Zhou X, Zhang J, Huang T, Hou B, Du C, Wang S, Mo Y, Yu N, Zhou S, You J, Zhang Z, Huang G, Zeng X (2014) Cytochrome b5 reductase 2 is a novel candidate tumor suppressor gene frequently inactivated by promoter hypermethylation in human nasopharyngeal carcinoma. Tumour Biol 35:3755–3763CrossRefGoogle Scholar
  3. 3.
    Choi YJ, Kim MS, An CH, Yoo NJ, Lee SH (2014) Regional bias of intratumoral genetic heterogeneity of nucleotide repeats in colon cancers with microsatellite instability. Pathol Oncol Res 20:965–971CrossRefPubMedGoogle Scholar
  4. 4.
    Marusyk A, Almendro V, Polyak K (2012) Intra-tumour heterogeneity: a looking glass for cancer? Nat Rev Cancer 12:323–334CrossRefPubMedGoogle Scholar
  5. 5.
    Oh HR, An CH, Yoo NJ, Lee SH (2015) Frameshift mutations of MUC15 gene in gastric and its regional heterogeneity in gastric and colorectal cancers. Pathol Oncol Res 21:713–718CrossRefPubMedGoogle Scholar

Copyright information

© Arányi Lajos Foundation 2018

Authors and Affiliations

  1. 1.Department of Pathology, College of MedicineThe Catholic University of KoreaSeoulSouth Korea

Personalised recommendations